Nucitec   Report issue

For profit Phase 2 Phase 3
Founded: Querétaro Mexico (1999)
Status: No NME R&D (1999)

Organization Overview

First Clinical Trial
2006
NCT01505023
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Nucitec SA de CV | NUCITEC S.A. de C.V.

Active Ingredients

Drugs in Phase 3 Trials (2)

methylprednisolone (medrol) (1 trial)

sodium bicarbonate (1 trial)

Drugs in Phase 2 Trials (1)

inulin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Obesity (Phase 2)

Osteoarthritis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3